Previous studies have demonstrated that the expression of several
growth factors including
glial cell-derived neurotrophic factor (
GDNF),
brain-derived growth factor (
BDNF), and neurotrophin-3 (NT-3) play an important role in defining neuronal survival after
brain ischemia. In the present study, using a well-defined model of transient spinal
ischemia in rat, we characterized the changes in spinal
GDNF,
BDNF, and NT-3 expression as defined by
enzyme-linked
immunosorbent assay (ELISA) and immunofluorescence coupled with deconvolution microscopy. In control animals, baseline levels of
GDNF,
BDNF, and NT-3 (74 +/- 22, 3,600 +/- 270, 593 +/- 176 pg/g tissue, respectively) were measured. In the ischemic group, 6 min of spinal
ischemia resulted in a biphasic response with increases in tissue
GDNF and
BDNF concentrations at the 2-hr and 72-hr points after
ischemia. No significant differences in NT-3 concentration were detected. Deconvolution analysis revealed that the initial increase in tissue
GDNF concentration corresponded to a neuronal upregulation whereas the late peak seen at 72 hr corresponded with increased astrocyte-derived
GDNF synthesis. Increased expression of
BDNF was seen in neurons, astrocytes, and oligodendrocytes. These data suggest that the early increase in neuronal
GDNF/
BDNF expression likely modulates neuronal resistance/recovery during the initial period of postischemic reflow. Increased astrocyte-derived
BDNF/
GDNF expression corresponds with transient activation of astrocytes and may play an active role in neuronal plasticity after non-injurious intervals of spinal
ischemia.